The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy by Fehr, Stephanie et al.
The following article appeared in Fehr, Stephanie and Wilson, Meredith and Downs, Jenny and 
Williams, Simon and Murgia, Alessandra and Sartori, Stefano and Vecchi, Marilena and Ho, Gladys 
and Polli, Roberta and Psoni, Stavroula and Bao, Xinhua and de Klerk, Nick and Leonard, Helen and 
Christodoulou, John. 2012. The CDKL5 disorder is an independent clinical entity associated with 
early-onset encephalopathy. European Journal of Human Genetics. 21: 266-273. 






Title: The CDKL5 disorder is an independent clinical entity associated with early-
onset encephalopathy 
 





Telethon Institute for Child Health Research, Centre for Child Health Research, The 
University of Western Australia, Perth, Western Australia, Australia 
 
Meredith Wilson 
Western Sydney Genetics Program, Children’s Hospital at Westmead, Sydney, 
Australia 





The Telethon Institute for Child Health Research, Centre for Child Health Research, 
University of Western Australia, Perth, Western Australia, Australia 
School of Physiotherapy and Curtin Health Innovation Research Institute, Curtin 
University, Perth, Western Australia, Australia 
 
Simon Williams 




Department of Pediatrics, University of Padua, Padua, Italy 
 
Stefano Sartori 
Department of Pediatrics, University of Padua, Padua, Italy 
 
Marilena Vecchi 
Department of Pediatrics, University of Padua, Padua, Italy 
 
Gladys Ho 
Western Sydney Genetics Program, Children’s Hospital at Westmead, Sydney, 
Australia 
Discipline of Paediatrics & Child Health, University of Sydney, Sydney, Australia 
 
Roberta Polli 
Department of Pediatrics, University of Padua, Padua, Italy 
 
Stavroula Psoni 
Medical Genetics, University of Athens, Athens, Greece 
 
Xinhua Bao 
Department of Pediatrics, Peking University First Hospital, Beijing, 100034 P. R. China 
 
Nick de Klerk 
The Telethon Institute for Child Health Research, Centre for Child Health Research, 
University of Western Australia, Perth, Western Australia, Australia 
 
Helen Leonard 
The Telethon Institute for Child Health Research, Centre for Child Health Research, 
University of Western Australia, Perth, Western Australia, Australia 
 
John Christodoulou  
Western Sydney Genetics Program, Children’s Hospital at Westmead, Sydney, 
Australia 




Professor John Christodoulou  
Western Sydney Genetics Program and Sydney Medical School 
University of Sydney, Sydney, NSW, Australia. 
t: +612 9845 3452 
f: +612 9845 1864 
e: john.christodoulou@health.nsw.gov.au 
ABSTRACT 
The clinical understanding of the CDKL5 disorder remains limited, with most 
information being derived from small patient groups seen at individual centres. This 
study uses a large international data collection to describe the clinical profile of the 
CDKL5 disorder and compare with Rett syndrome. Information on individuals with 
CDKL5 mutations (n=86) and females with MECP2 mutations (n=920) was sourced 
from the InterRett database. Available photographs of CDKL5 patients were examined 
for dysmorphic features. The proportion of CDKL5 patients meeting the recent Neul 
criteria for atypical Rett syndrome was determined. Logistic regression and time-to–
event analyses were used to compare the occurrence of Rett-like features in those with 
MECP2 and CDKL5 mutations. Most individuals with CDKL5 mutations had severe 
developmental delay from birth, seizure onset before the age of three months and 
similar non-dysmorphic features. Less than one quarter met the criteria for early-onset 
seizure variant Rett syndrome. Seizures and sleep disturbances were more common than 
in those with MECP2 mutations while features of regression and spinal curvature were 
less common. The CDKL5 disorder presents with a distinct clinical profile and a subtle 
facial, limb and hand phenotype that may assist in differentiation from other early-onset 
encephalopathies. Although mutations in the CDKL5 gene have been described in 
association with the early onset variant of Rett syndrome, in our study the majority did 
not meet these criteria. Therefore, the CDKL5 disorder should be considered separate to 
Rett syndrome, rather than another variant.  
 
 




Mutations in the cyclin-dependent kinase-like 5 (CDKL5) gene have been found in 
individuals diagnosed with the early-onset seizure variant of Rett syndrome (ESV RTT), 
infantile spasms or West syndrome. In 2003, chromosomal rearrangements involving 
the CDKL5 gene were identified in two females with severe intellectual disability and 
early-onset seizures
1
 and the following year in four females with Rett syndrome 
(RTT).
2,3
 To date, 141 individuals (127 females and 14 males) with a CDKL5 mutation 
have been described, mostly within small case series,
1-38
 the largest including 20 
patients.
11
 Therefore the understanding of the CDKL5 disorder profile is still limited 
and a larger series is required to further understand its presentation and natural history. 
 
The clinical characteristics commonly associated with a CDKL5 mutation include early-
onset seizures and severe intellectual and gross motor impairment. The ESV RTT was 
originally described in a girl with RTT who developed seizures by one year of age.
39
 
The recently published Neul criteria
40
 for atypical RTT included five specific items 
(early-onset seizures before 5 months of age, infantile spasms, refractory myoclonic 
epilepsy, seizure onset before regression and decreased frequency of typical RTT 
features) for differentiating the ESV from other atypical forms. The number of 
distinguishing criteria required for a diagnosis of ESV RTT was not clear although 
testing for a CDKL5 mutation was recommended. 
 
Various dysmorphic features have also been described in individuals with a CDKL5 
mutation including large deep-set eyes, strabismus, high forehead, full lips, wide mouth 
and widely spaced teeth.
1,4,5,7,13,18,20,22,25,26,28-30,35
 The presence of typical facial or other  
3 
features could provide additional assistance in the clinical identification of individuals 
with a CDKL5 mutation. 
 
Here we describe the phenotype of females and males with a pathogenic or potentially 
pathogenic CDKL5 mutation, identified through the International Rett Syndrome 
Phenotype Database (InterRett).
41
 We assessed whether individuals with a CDKL5 
mutation shared similar characteristics of the face, hands and feet. We determined 
whether these individuals met the latest criteria for ESV RTT
40
 and compared the 
presence of RTT features in females who have a CDKL5 mutation with females who 
have a pathogenic MECP2 mutation.  
 
METHODS 
InterRett is an international Rett syndrome database which has ascertained over 2000 
RTT cases worldwide since 2003.
41
 Since 2007, partly through the advocacy of the 
family support group, families of an individual with a CDKL5 mutation have been 
invited to complete an InterRett questionnaire. Families also provided photographs of 
their son or daughter’s face (frontal and side), hands (dorsal and palmar) and feet 
(dorsal and plantar). A comparison group of females with RTT and a pathogenic 
MECP2 mutation was also obtained from the InterRett database.  
 
Data from family and clinician questionnaires, concerning acquisition of gross motor 
milestones, purposeful hand function and speech, presence of hand stereotypies, 
seizures, gastrointestinal problems, spinal curvature (scoliosis or kyphosis), autonomic 
problems and sleep problems were examined. All photographs of patients with CDKL5 
mutations were reviewed by a clinical geneticist (MW) and the characteristics noted 
were tabulated.  
 
Approval for this study was provided by the Princess Margaret Hospital for Children 
Ethics Committee, Perth, Western Australia. 
 
Statistical analysis 
The phenotypical characteristics of the CDKL5 disorder and the difference between 
females and males were determined using descriptive statistics. The proportion of 
CDKL5 disorder individuals that met each of the criteria for ESV RTT, by sex and age 
(aged five years and under or over five years) was determined. Clinical features known 
to be associated with RTT were compared between females with a CDKL5 mutation and 
females with a MECP2 mutation. Odds ratios adjusting for age were estimated. Survival 




Seventy-seven females and nine males with a CDKL5 mutation were included in this 
study (supplementary table 1 contains genetic information). Age at ascertainment 
ranged from 6 months to 22.4 years (mean 6.1 years, median 4.7 years) for females and 




Seizures and motor delay 
Seizures occurred in all except one female, and in all males, at a mean age of 7.3 weeks 
(range 0.3 to 34.8) and 6.4 weeks (2.1 to 13.0 weeks) respectively. Seizures occurred by 
three months of age in 90%. At ascertainment, 52/72 females and 8/9 males had daily 
seizures, 5/72 females had weekly seizures, 10/72 females and 1/9 males had monthly 
seizures, while the remaining five females had no seizures in the last year. Nine families 
reported that their child was no longer treated with anticonvulsant medications. 
 
Severe gross motor delay was reported in all but three females. The ability to sit was 
acquired by just over half (41/75, 54.7%) of the females (mean age 25.2 months, median 
18.2 months, range 6 months to 14 years) and by one male at 8 months. Eight (10.8%) 
females achieved independent walking at a mean age of 39.6 months (95% CI 28.2-
51.1, and median 38 months, range 1.4-5.5 years). A further nine (13.6%) females 
walked with assistance (mean age 41.2 months, 95% CI 26.4-55.9, range 1.6-5 years). 
No males were able to walk, with or without assistance. 
 
Hand function and speech 
Functional hand use was acquired by just over half (43/72) of females and 1/8 males, of 
whom 11/37 (29.8%) females and no males lost the ability. Early speech skills (ranging 
from babble to single words) were acquired by 30/76 (39.5%) females and 2/9 (22.2%) 
males, of whom 14/29 (48.3%) females and no males subsequently lost speech. Families 
of 57/72 females and 6/8 males felt that their child could communicate non-verbally 
(e.g. facial expressions, sign language and/or eye pointing) and families of 56/72 
females and 6/8 males felt their child was able to follow simple commands and respond 
to changes in tone of voice.  
 
RTT-like features and co-morbidities 
Hand stereotypies developed in 61/76 (80.3%) females (mean age 13.1 months, median 
1 year, range 3 months to 5.5 years). In comparison only 3/9 (33.3%) males developed 
stereotypies at 3, 12 and 24 months (p=0.004). In the majority (41/56, 73.2%) more than 
one type of hand stereotypy was present, the most frequently described being mouthing 
(n=36/56), wringing (n=18/56), clapping (n=18/56), biting (n=12/56) and clasping 
(n=11/56). Regression in skills occurred in 25/77 (32.5%) females (mean age of 18.5 
months) and no males. 
 
Gastrointestinal problems, such as constipation and reflux, were present in 59/75 
(78.7%) of females and in 8 males. A spinal curvature was reported in 20.5% (15/73) of 
females (mean age of onset (where known) 7.6 years, range 2 to 14 years) and one third 
of the males (age range 4 to 13 years). Autonomic problems, such as cold feet, were 
present in just under half of females (30/73, 41.1%) and 3/8 of males, whilst sleep 
problems occurred in 89.9% (62/69) of females and 87.5% (7/8) males. Head growth 




Initial review of photographs (60 females and 7 males) indicated that “dysmorphism” 
was subtle. Frequently observed facial features included: a prominent and/or broad 
forehead; high hairline; relative mid-face hypoplasia; deep-set but “large”-appearing 
eyes and infra-orbital shadowing (Figure 1). Eyebrows were usually well defined and 
tended to be straight rather than arched. Synophrys was present in 13.4% overall but 
was more prevalent in males (42.9%). Lips were full in most, often with eversion of the 
lower lip. Ears were normally placed and of normal configuration. Young children 
tended to have a low nasal bridge, mildly anteverted nares, prominent nasal tip and a 
well-defined (normal) philtrum (Table 1). With age the facial appearance tended to 
coarsen, but the nasal profile remained notably straight in nearly all individuals.  
 
The fingers in young children were often tapered, some with puffy proximal and 
narrowed distal phalanges. Some had a puffy dorsum of the hands and/or feet. In older 
individuals, the fingers tended to be slender, with prominent proximal interphalangeal 
(IP) joints and narrow distal IP joints. Hallux valgus was present in 25%. Some had 
relatively long great toes, with slightly broad toenails. Toes 2-5 were usually very 
regular in shape and position, with mild brachydactyly (Table 1).  
 
The spectrum of features was similar overall in females and males, but 5/7 males had a 
distinctly anteverted nasal tip, two of whom had a short philtrum and retracted, everted 
upper lip. Only one female had anteverted nares; she also had a receding forehead and 
laterally upswept eyebrows; she had a 2.7Mb deletion including the CDKL5 and NHS 




Fulfilment of criteria for ESV RTT 
Overall 19/75 (23.7%) females and no males fulfilled all criteria for ESV RTT (Table 
3). This was largely due to the absence of regression in all males and 67.5% of females. 
Hand function was lost by only 16.7% and spoken language by only 18.7% of females. 
No male lost either hand function or spoken language. Gait abnormalities were the most 
widely met main criterion. Bruxism, impaired sleep and abnormal muscle tone were the 
most widely met supportive criteria. 
 
More females aged over 5 years (12/36) met all criteria in comparison to those aged 5 
years and under (7/39) (Table 3).  Just under half of the females aged over 5 years had 
developed a spinal curvature, compared to less than 5% of those aged 5 years and under. 
In males all those aged over 5 years had a spinal curvature compared to none of those 
less than 5 years. Peripheral vasomotor disturbances were also reported more frequently 
in the older group in both females and males. 
 
Comparison between females with the CDKL5 disorder and females with RTT 
There were a total of 920 females with a clinical diagnosis of RTT and a pathogenic 
MECP2 mutation. Data was available from both families and clinicians (n=574) and 
from clinicians only (in de-identified form, n=346). The mean age of the females with 
RTT was 10.5 years (range 1.3 to 54.2 years). After adjusting for age, females with the 
CDKL5 disorder were more likely to have seizures (OR 54.01, 95% CI 7.45-391.33) 
and sleep disturbances (OR 4.89, 95% CI 2.20-10.89) than females with RTT (Table 4). 
They were less likely to have breathing disturbances (OR 0.43 95%, CI 0.26-0.71), a 
spinal curvature (OR 0.34, 95% CI 0.17-0.65) and gastrointestinal problems (OR 0.52, 
95% CI 0.27-0.98); to develop hand stereotypies (OR 0.12, 95% CI 0.06-0.25) and to 
lose hand (OR 0.06, 95% CI 0.03-0.12) and speech skills (OR 0.13, 95% CI 0.07- 0.23).  
 
Time to event analysis (Figures 2-4) showed that females with the CDKL5 disorder 
were more likely to develop seizures earlier, with three quarters of females having 
developed epilepsy before 12 months of age compared to 10 years for RTT (HR 24.8, 
95% CI 18.6-32.9). Hand stereotypies also appeared earlier in females with the CDKL5 
disorder, with 75% having developed them by two years of age compared to 75% by 
three years for females with RTT (HR 1.1, 95% CI 0.86-1.5). A spinal curvature was 
less likely in females with the CDKL5 disorder compared to females with RTT (HR 
0.51, 95% CI 0.28-0.90).  
 
The most characteristic features of females and males with the CDKL5 disorder are 
shown in Table 5. These features can be used as a guide to assist decision-making where 
targeted CDKL5 mutation analysis is being considered. 
 
DISCUSSION 
Individuals with mutations in the CDKL5 gene have been variably classified as having 
early infantile epileptic encephalopathy, X-linked dominant infantile spasm syndrome, 
the ESV RTT or diagnosed with other epileptic disorders such as West syndrome.
1,3
 We 
described the clinical presentation and physical appearance of individuals with the 
CDKL5 disorder, providing information from a large international dataset. The CDKL5 
disorder appears to be characterised by seizure onset in the majority before three months 
of age, severely impaired gross motor, language and hand function skills, and subtle but 
6 
shared physical characteristics such as a prominent/broad forehead, deep-set but large-
appearing eyes, full lips and tapered fingers. Our findings suggest that the CDKL5 
disorder is an independent entity and should not be considered part of the RTT 
spectrum, as less than 25% of the cases in our study would meet the clinical criteria for 
ESV RTT. Therefore we propose that females and males with a mutation in the CDKL5 
gene be given a specific diagnosis of the CDKL5 disorder. 
 
Our study found that early-onset epilepsy was one of the hallmark features of the 
CDKL5 disorder. In the literature many seizure types and EEG changes have been 
described. These include infantile spasms, multifocal and generalised seizures with 
myoclonic, tonic (tonic vibratory) and clonic features. Reported EEG patterns include a 
normal background, background slowing and a burst-suppression pattern.
10,12
 Whilst no 
specific seizure semiology has been described, two reports have noted a seizure pattern 
that may be unique to this disorder.
31,34
 The first (n=4) reported a seizure pattern of 
tonic-tonic/vibratory contraction, followed by a clonic phase with spasms and finishing 
with distal myoclonus.
34
 The second (n=4) reported an initial hypermotor phase, then 
tonic extension, followed by spasms. Severe developmental delay was typical of the 
CDKL5 disorder. Learning to sit and walk was usually considerably delayed or not 
achieved, more so in males.
42
 Communication was usually restricted to non-verbal 
strategies. It would be important to further investigate the influences of genotype, 
seizure severity or therapy utilization on early development in those with the CDKL5 
disorder. Consistent with other literature
1-38
 our large case series confirms that early-
onset of epilepsy and severe developmental delay are key features.  
 
Males with the CDKL5 disorder in this study tended to be more severely affected. None 
learned to walk, with or without assistance, and few acquired spoken communication 
and hand function. Seizure onset was slightly earlier than in females, and all males were 
having either daily or monthly seizures.  Hand stereotypies were reported in only a third 
of males compared to 80% of females. Some of these differences may be due to 
amelioration of the phenotype in females because of X-inactivation resulting in a 
mosaic expression of normal and mutant CDKL5 protein. In RTT, males tend to be 
either extremely affected, often dying at an early age due to severe infantile 
encephalopathy, or more mildly affected than females.
43
 Those who are more mildly 
affected tend to have hypomorphic MECP2 mutations that are not found in females with 
RTT. It would be of interest to further investigate the genetic variability between males 
and females with the CDKL5 disorder to determine whether a similar phenomenon 
exists. 
 
We observed a shared physical resemblance between females with the CDKL5 disorder, 
with the most consistent features being a prominent/broad forehead, deep-set but “large-
appearing” eyes, full lips and tapered fingers. Most affected males were more obviously 
dysmorphic, with distinctly anteverted nares and several males also had a short philtrum 
and everted upper lip. Previous studies of the CDKL5 disorder have also reported 
dysmorphic features including: large deep-set eyes, strabismus, high forehead, full lips, 
wide mouth, widely spaced teeth and a high palate.
1,4,5,7,13,18,20,22,25,26,28-30,35
 Dysmorphic 
features have been described in other conditions presenting with early-onset 
encephalopathy, such as those with FOXG1 mutations and in Pitt-Hopkins syndrome 
(PHS). In those with FOXG1 mutations, subtle, non-specific dysmorphic features have 
been reported, along with severe microcephaly, which is typical of FOXG1 syndrome 
but not common in individuals with the CDKL5 disorder.
44
 The facial features in PHS 
include a high nasal bridge and prominent, beaked nose, different from the consistently 
straight nose and normal or low nasal bridge seen in the CDKL5 disorder. While both 
can have prominent lips, the lips in PHS have a more marked cupid’s-bow contour. 
Individuals with PHS may have clubbing of the fingertips whereas in the CDKL5 
disorder the distal phalanges are relatively narrow and/or short.
45
 In classical RTT no 
typical facial gestalt has been described, although some clinicians have suggested a 
facial similarity to Angelman syndrome.
46
 A recent study using a combination of 
measurement and subjective impression found the only distinctive facial profile 
difference in RTT was a relatively broad upper face, especially in girls less than three 
years old.
47
 Whilst subtle, the features that we have described appear to be characteristic 
of the CDKL5 disorder population, and could therefore be useful in determining 
whether the patient warranted CDKL5 specific mutation testing. 
 
The majority of patients in this study with the CDKL5 disorder did not meet the new 
criteria for the ESV RTT, mainly due to the absence of regression in over two-thirds. 
Several of the specific supportive criteria, such as diminished response to pain, a spinal 
curvature and intense eye pointing, were also infrequently reported. Some of these 
supportive characteristics appear age-dependent and were observed more commonly in 
those aged over five years. Longitudinal monitoring of these features would contribute 
to a better understanding of the evolution of this disorder.  
 
Considering only the females with the CDKL5 disorder, the differences in comparison 
to RTT persisted. Early development was more severely impaired in those with the 
CDKL5 disorder, with approximately half learning to sit and 10% learning to walk in 
comparison to approximately 80% learning to sit and just under half learning to walk in 
a recent study of 293 females with RTT.
48
 Those with the CDKL5 disorder were less 
likely to use words whereas use of some words was acquired by nearly 90% of females 
with RTT before regression.
48
 Females with the CDKL5 disorder were also less likely to 
develop hand stereotypies, breathing disturbances, gastrointestinal problems and a 
spinal curvature, but were much more likely to develop seizures and have sleep 
disturbances. These findings again suggest that the CDKL5 disorder is clinically 
separate to RTT, indicating the need to develop independent clinical criteria for the 
identification of the CDKL5 disorder. 
 
The two largest studies conducted to date (n=9 and n=20) found that the classical period 
of regression was rarely present in females with the CDKL5 disorder and that 
autonomic, gastrointestinal, breathing and spinal problems were rare and lack of eye 
contact, hypotonia and epilepsy common.
11,22
 Our study also found that regression, 
autonomic disturbances, breathing disturbances and a spinal curvature occurred less 
frequently than in RTT, but that the prevalence increased with age. Gastrointestinal 
problems were quite common, although occurring less frequently than in females with 
RTT. In contrast to other CDKL5 studies
1-38
 we found that sleep problems were 
reported frequently.  Small case series may be less likely to accurately identify some of 
the patterns detectable by a larger study, which could account for this difference. 
Clearly large sample sizes, preferably population-based, are needed to provide accurate 
representation of the clinical features of such a rare condition. Our study is the first to 
have had the capacity to compare the characteristics of males and females with the 
CDKL5 disorder. Further investigation of the natural history is still required, and there 
are likely other features that have not been captured by existing studies. 
 
This study is the first international case collection investigating the clinical presentation 
of the CDKL5 disorder and includes more than four times the number of individuals 
than the largest previously reported case series. It is also the first to examine whether 
these individuals meet the criteria set forth for the ESV RTT. However, our study is not 
population-based, and we suggest the development of a population-based register of this 
disorder, as has occurred in RTT.
49
 Because we used the infrastructure of InterRett, our 
data collection tools were initially designed for RTT and therefore we may not have 
been able to capture the presence of features that are unique to the CDKL5 disorder. 
Our study population was also weighted towards younger children, and some clinical 
features are likely to evolve with age. With regard to the identification of “dysmorphic” 
features, our study was limited by the lack of a photographic control group, the variable 
quality of images used, and the subjective nature of the assessments (although the latter 
has been a traditional approach to dysmorphology). Acknowledging these limitations, 
and that the features noted were variable, we felt the combined gestalt in a child with 
early onset encephalopathy, without major malformations, could suggest a CDKL5 
mutation as a likely underlying aetiology.  
 
Many of the early-onset encephalopathies have overlapping phenotypes, including 
severe developmental compromise with or without prior regression, early-onset 
seizures, abnormal movements (stereotypies or dyskinesias) and respiratory 
irregularities. Some are distinctive either by dysmorphism (PHS), or typical 
neurodevelopmental profile (classical RTT). Others may be less easily recognised, 
which is why classifications evolve using terms like “Rett variant” or “PHS-like”. 
While use of such terms in some conditions (e.g. Noonan or Noonan-like) has been 
borne out by discovering mutations in genes in shared pathways, this type of 
classification should be approached with some caution. Although mutations in the 
CDKL5 gene have been found in association with a clinical picture similar to RTT in 
some instances, the majority of cases are different. It may be more accurate and 
beneficial for families and clinicians if the CDKL5 disorder is considered independent 
of RTT, rather than another variant. Therefore we suggest that when describing the 
clinical picture of females and males with the CDKL5 disorder, researchers should not 
only concentrate on features which should be present in RTT, but rather the features 
which are present in the CDKL5 disorder. Only then will it be possible to develop 
accurate clinical diagnostic and management guidelines. 
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Titles and legends to figures 
Figure 1. Examples of identified facial, hand and feet features in males and females with 
the CDKL5 disorder (n=67). 
 
A. Female aged one year 10 months: high/prominent forehead, deep-set eyes, prominent 
lips, well-defined philtrum, proximal puffy phalanges and tapered fingers. 
B. Female aged two years: high/prominent forehead, deep-set eyes, prominent lips, 
well-defined philtrum, tapered fingers, slightly broad hallux, hallux valgus and 
“regular” toes. 
C. Female aged four years: deep-set eyes, a well-defined philtrum, laterally orientated 
nasal apertures, prominent lips, slightly tapered fingers, small distal phalanges and a 
broad hallux. 
D. Female aged three years two months: prominent forehead, mild synophrys, deep-set 
eyes, prominent lips, puffy proximal phalanges, tapered fingers, slightly broad hallux, 
and “regular” other toes. 
E. Female aged seven years 11 months: high/prominent forehead, deep-set eyes, everted 
lower lip, puffy proximal phalanges, prominent proximal IP joints and tapered fingers. 
F. Female aged 14 years: broad forehead, deep-set eyes, epicanthic folds, well-defined 
philtrum, prominent lips, tapered fingers and prominent proximal IP joints. 
G. Female aged 24 years and two months: high forehead, deep-set eyes, well defined 
philtrum and prominent lips.  
H. Male aged four years four months: high/prominent forehead, well-defined philtrum, 
prominent lips, tapered fingers and “regular” toes. 
 
Figure 2. Kaplan-Meier survival curve for the risk of developing seizures by single year 
of age. 
 
Figure 3. Kaplan-Meir survival curve of the risk of developing hand stereotypies by 
single year of age.  
 
Figure 4. Kaplan-Meier survival curve for the risk of developing a spinal curvature by 












Table 1. Distribution of observed dysmorphic features identified in 60 females and 7 
males with the CDKL5 disorder. 
Feature Number of cases (%) 
Broad/prominent forehead 46/62 (74.2) 
High forehead (not broad) 5/62 (8.1) 
Receding or narrow forehead 3/62 (4.8) 
Deep set eyes 49/67 (73.1) 
Synophrys (5 females, 3 males) 8/67 (13.4) 
Well-defined philtrum 40/66 (60.6) 
Full lips/everted lower 45/67 (67.2) 
Fingers proximally puffy/prominent proximal IP joint 26/62 (41.9) 
Hallux valgus 16/64 (25.0) 
 
 
 
